T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive lymphoid malignancy, with a poor response to chemotherapy and unfavorable prognosis. The presented clinical case demonstrates the effectiveness of allogeneic hematopoietic stem cell transplantation (allo-HSCT) using a non-myeloablative conditioning regimen in a patient with T-PLL and provides a literature review on this issue.
No takes yet. Share an insight, caveat, or question.
Krylova et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: